27 July 2020 - A White House meeting with pharmaceutical executives that President Trump said would occur on Tuesday is now off, people familiar with the matter said.

A pharmaceutical industry source said that "there was concern that this would not have been a productive meeting" and that companies are still discussing how to move forward after Trump signed a series of executive orders on Friday taking aim at drug prices.

Trump had announced during Friday's signing ceremony that there would be a meeting at the White House with industry executives on Tuesday, which he said would give drug companies a chance to propose an alternative to one of his executive orders. Drug companies, however, never publicly confirmed that they would attend the meeting.

Read The Hill article